Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanni Monteleone

Showing results (41-50 of 384) with videos related to

Pageof 39
Sort By:
Inflammation & Allergy Drug Targets|December 28, 2010
Cytokine therapies in Crohn's disease: where are we now and where should we go?Flavio Caprioli, Francesco Pallone, Giovanni Monteleone
World Journal of Gastroenterology|October 24, 2007
Emerging role of IL-23/IL-17 axis in H pylori-associated pathologyRoberta Caruso, Francesco Pallone, Giovanni Monteleone
Mediators of Inflammation|June 9, 2009
Interleukin-23 and Th17 cells in the control of gut inflammationIvan Monteleone, Francesco Pallone, Giovanni Monteleone
European Journal of Gastroenterology & Hepatology|April 27, 2021
Paradoxical hidradenitis suppurativa in Crohn's disease patients receiving infliximab: a case report and review of literatureSilvia Salvatori, Irene Marafini, Giovanni Monteleone
Annals of Medicine|December 1, 2010
Th17-cytokine blockers as a new approach for treating inflammatory bowel diseaseIvan Monteleone, Francesco Pallone, Giovanni Monteleone
World Journal of Gastroenterology|September 29, 2006
Interleukin-12 and Th1 immune response in Crohn's disease: pathogenetic relevance and therapeutic implicationIlaria Peluso, Francesco Pallone, Giovanni Monteleone
Gut and Liver|June 3, 2020
Expression of Receptors for SARS-CoV-2 in the Gut of Patients with Inflammatory Bowel DiseaseGiovanni Monteleone, Eleonora Franzè, Federica Laudisi
Expert Review of Clinical Immunology|September 19, 2018
Targeting IL-23 in Crohn's diseaseSilvia Sedda, Gerolamo Bevivino, Giovanni Monteleone
International Journal of Molecular Sciences|September 4, 2012
Molecular targets of TRAIL-sensitizing agents in colorectal cancerCarmine Stolfi, Francesco Pallone, Giovanni Monteleone
International Journal of Molecular Sciences|October 31, 2012
The dual role of inflammation in colon carcinogenesisGiovanni Monteleone, Francesco Pallone, Carmine Stolfi
Pageof 39

Showing results (41-50 of 384) with videos related to

Sort By:
Pageof 39
Inflammation & Allergy Drug Targets|December 28, 2010
Cytokine therapies in Crohn's disease: where are we now and where should we go?Flavio Caprioli, Francesco Pallone, Giovanni Monteleone
World Journal of Gastroenterology|October 24, 2007
Emerging role of IL-23/IL-17 axis in H pylori-associated pathologyRoberta Caruso, Francesco Pallone, Giovanni Monteleone
Mediators of Inflammation|June 9, 2009
Interleukin-23 and Th17 cells in the control of gut inflammationIvan Monteleone, Francesco Pallone, Giovanni Monteleone
European Journal of Gastroenterology & Hepatology|April 27, 2021
Paradoxical hidradenitis suppurativa in Crohn's disease patients receiving infliximab: a case report and review of literatureSilvia Salvatori, Irene Marafini, Giovanni Monteleone
Annals of Medicine|December 1, 2010
Th17-cytokine blockers as a new approach for treating inflammatory bowel diseaseIvan Monteleone, Francesco Pallone, Giovanni Monteleone
World Journal of Gastroenterology|September 29, 2006
Interleukin-12 and Th1 immune response in Crohn's disease: pathogenetic relevance and therapeutic implicationIlaria Peluso, Francesco Pallone, Giovanni Monteleone
Gut and Liver|June 3, 2020
Expression of Receptors for SARS-CoV-2 in the Gut of Patients with Inflammatory Bowel DiseaseGiovanni Monteleone, Eleonora Franzè, Federica Laudisi
Expert Review of Clinical Immunology|September 19, 2018
Targeting IL-23 in Crohn's diseaseSilvia Sedda, Gerolamo Bevivino, Giovanni Monteleone
International Journal of Molecular Sciences|September 4, 2012
Molecular targets of TRAIL-sensitizing agents in colorectal cancerCarmine Stolfi, Francesco Pallone, Giovanni Monteleone
International Journal of Molecular Sciences|October 31, 2012
The dual role of inflammation in colon carcinogenesisGiovanni Monteleone, Francesco Pallone, Carmine Stolfi
Pageof 39